ProCE Banner Series

Neo/Adjuvant Immunotherapy in Resectable Melanoma: Implementing Novel and Emerging Strategies to Improve Outcomes in Community Practice

This live, interactive webinar will discuss the latest clinical pearls, data, and recommendations related to neo/adjuvant immunotherapy in resectable melanoma.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This educational program is intended for medical oncologists, dermatologists, surgeons, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals caring for patients with melanoma.

All Events

Neo/Adjuvant Immunotherapy in Resectable Melanoma: Implementing Novel and Emerging Strategies to Improve Outcomes in Community Practice

Past Events

October

25

2024

9:00 AM - 10:00 AM Central Time (CT)

Virtual

CCO Simulcast | Host Group OK, Yukon, Oklahoma

Faculty

ProCE Banner Faculty
Sapna P. Patel, MD

Dr. William Robinson Endowed Chair in Cancer Research
Director, Cutaneous Oncology and Cell Therapy for Solid Tumors
Professor of Medicine and Ophthalmology
University of Colorado
Aurora, Colorado

ProCE Banner Faculty
Govind Warrier, MD, MPH

Assistant Professor, Medical Oncology
Melanoma/Skin Cancer and Cancer Immunology Programs
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with resectable melanoma. 

Target Audience
This educational program is intended for medical oncologists, dermatologists, surgeons, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals caring for patients with melanoma. 

Learning Objectives
Upon completion of this event, participants should be able to:

  • Evaluate the clinical rationale for and evidence supporting the use of immunotherapy in early-stage melanoma, with a focus on neo/adjuvant immunotherapy for stage IIB/C disease
  • Apply current guidelines, indications, and clinical trial evidence to develop individualized treatment plans for the use of neo/adjuvant immunotherapy for stage IIB/C melanoma, with consideration for recurrence prevention, outcome improvement, and management of immune-related adverse events
  • Integrate recommended strategies to improve the multidisciplinary care of patients with early-stage melanoma who are eligible for immunotherapy, including multidisciplinary teams for treatment selection and management of immune-related adverse events
  • Use shared decision-making and effective communication approaches and resources to support patient engagement in care and to more effectively design and implement personalized treatment plans that align with patients' unique goals and preferences
  • Identify patients with early-stage melanoma who are eligible for enrollment on clinical trials investigating immunotherapy-based regimens

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: Specific to each event.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC, in partnership with AIM at Melanoma Foundation.

Supported by an educational grant from Bristol-Myers Squibb.